1. Home
  2. FNA vs FLGT Comparison

FNA vs FLGT Comparison

Compare FNA & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FNA
  • FLGT
  • Stock Information
  • Founded
  • FNA 2010
  • FLGT 2011
  • Country
  • FNA United States
  • FLGT United States
  • Employees
  • FNA N/A
  • FLGT N/A
  • Industry
  • FNA Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • FLGT Medical Specialities
  • Sector
  • FNA Health Care
  • FLGT Health Care
  • Exchange
  • FNA Nasdaq
  • FLGT Nasdaq
  • Market Cap
  • FNA 590.6M
  • FLGT 683.5M
  • IPO Year
  • FNA 2021
  • FLGT 2016
  • Fundamental
  • Price
  • FNA $10.00
  • FLGT $17.41
  • Analyst Decision
  • FNA Strong Buy
  • FLGT Hold
  • Analyst Count
  • FNA 5
  • FLGT 2
  • Target Price
  • FNA $15.60
  • FLGT $28.50
  • AVG Volume (30 Days)
  • FNA 817.5K
  • FLGT 237.8K
  • Earning Date
  • FNA 11-12-2024
  • FLGT 11-08-2024
  • Dividend Yield
  • FNA N/A
  • FLGT N/A
  • EPS Growth
  • FNA N/A
  • FLGT N/A
  • EPS
  • FNA N/A
  • FLGT N/A
  • Revenue
  • FNA $244,995,000.00
  • FLGT $277,761,000.00
  • Revenue This Year
  • FNA $17.47
  • FLGT N/A
  • Revenue Next Year
  • FNA $16.35
  • FLGT $14.04
  • P/E Ratio
  • FNA N/A
  • FLGT N/A
  • Revenue Growth
  • FNA 18.16
  • FLGT N/A
  • 52 Week Low
  • FNA $4.65
  • FLGT $17.31
  • 52 Week High
  • FNA $14.79
  • FLGT $30.68
  • Technical
  • Relative Strength Index (RSI)
  • FNA 76.69
  • FLGT 34.58
  • Support Level
  • FNA $5.07
  • FLGT $17.65
  • Resistance Level
  • FNA $10.68
  • FLGT $22.87
  • Average True Range (ATR)
  • FNA 0.66
  • FLGT 1.07
  • MACD
  • FNA 0.51
  • FLGT -0.32
  • Stochastic Oscillator
  • FNA 88.80
  • FLGT 4.89

About FNA Paragon 28 Inc.

Paragon 28 Inc is a medical devices company that develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products include plates and plating systems, screws, staples, and nails aimed to address all major foot and ankle procedures including ankle, Charcot, fracture fixation, hallux valgus, hammertoe, and flat foot. The company's suite of surgical solutions comprises nearly 80 product systems to help fit the specific needs of each patient and procedure. Geographically the company generates the majority of its revenue from the United States.

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

Share on Social Networks: